Litz H Van Dyke
First SEC filing: March 3, 2011 · Latest: March 3, 2011
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 30, 2026 | CARE | A | 12,300 | · | · | 79,767 Direct | +18.23% | Acquired | (price as of 2026-10-05) |
| March 4, 2026 | CARE | F | 819 | $20.98 | $17,183 | 67,467 Direct | -1.20% | Disposed | 45.4% (price as of 2026-10-05) |
| Feb. 25, 2026 | CARE | A | 4,870 | · | · | 61,088 Direct | +8.66% | Acquired | (price as of 2026-10-05) |
| Feb. 25, 2026 | CARE | A | 7,198 | · | · | 68,286 Direct | +11.78% | Acquired | (price as of 2026-10-05) |
| Feb. 14, 2026 | CARE | F | 1,158 | $22.01 | $25,488 | 56,218 Direct | -2.02% | Disposed | 38.6% (price as of 2026-10-05) |
| March 4, 2025 | CARE | A | 5,442 | · | · | 57,376 Direct | +10.48% | Acquired | (price as of 2026-10-05) |
| Feb. 27, 2025 | CARE | A | 8,279 | · | · | 53,737 Direct | +18.21% | Acquired | (price as of 2026-10-05) |
| Feb. 14, 2025 | CARE | F | 838 | $17.99 | $15,076 | 52,899 Direct | -1.56% | Disposed | 69.6% (price as of 2026-10-05) |
| Feb. 20, 2024 | CARE | F | 249 | $13.83 | $3,444 | 52,650 Direct | -0.47% | Disposed | 120.6% (price as of 2026-10-05) |
| Feb. 14, 2024 | CARE | F | 716 | $13.78 | $9,866 | 51,934 Direct | -1.36% | Disposed | 121.4% (price as of 2026-10-05) |
| Jan. 5, 2024 | CARE | A | 6,012 | · | · | 45,458 Direct | +15.24% | Acquired | (price as of 2026-10-05) |
| May 1, 2023 | CARE | P | 2,200 | $13.32 | $29,304 | 39,446 Direct | +5.91% | Acquired | 129.1% (price as of 2026-10-05) |
| Feb. 14, 2023 | CARE | A | 7,023 | · | · | 37,246 Direct | +23.24% | Acquired | (price as of 2026-10-05) |
| July 14, 2022 | CARE | P 10b5-1 | 76 | $13.03 | $990 | 30,223 Direct | +0.25% | Acquired | 134.2% (price as of 2026-10-05) |
| June 14, 2022 | CARE | P 10b5-1 | 73 | $13.60 | $993 | 30,147 Direct | +0.24% | Acquired | 124.3% (price as of 2026-10-05) |
| May 3, 2022 | CARE | P | 1,000 | $16.00 | $16,000 | 30,074 Direct | +3.44% | Acquired | 90.7% (price as of 2026-10-05) |
| March 7, 2022 | CARE | A | 6,373 | · | · | 29,074 Direct | +28.07% | Acquired | (price as of 2026-10-05) |
| Feb. 19, 2022 | CARE | F | 243 | $16.34 | $3,971 | 22,701 Direct | -1.06% | Disposed | 86.7% (price as of 2026-10-05) |
| Feb. 17, 2022 | CARE | A | 6,104 | · | · | 24,795 Direct | +32.66% | Acquired | (price as of 2026-10-05) |
| Feb. 17, 2022 | CARE | F | 1,851 | $16.03 | $29,672 | 22,944 Direct | -7.47% | Disposed | 90.3% (price as of 2026-10-05) |
| Dec. 14, 2021 | CARE | P 10b5-1 | 68 | $14.66 | $997 | 18,691 Direct | +0.37% | Acquired | 108.1% (price as of 2026-10-05) |
| Oct. 14, 2021 | CARE | P 10b5-1 | 66 | $14.80 | $977 | 18,623 Direct | +0.36% | Acquired | 106.1% (price as of 2026-10-05) |
| June 1, 2021 | CARE | P 10b5-1 | 129 | $15.41 | $1,988 | 18,557 Direct | +0.70% | Acquired | 98.0% (price as of 2026-10-05) |
| May 3, 2021 | CARE | P 10b5-1 | 150 | $13.20 | $1,980 | 18,428 Direct | +0.82% | Acquired | 131.1% (price as of 2026-10-05) |
| April 1, 2021 | CARE | P 10b5-1 | 143 | $13.95 | $1,995 | 18,278 Direct | +0.79% | Acquired | 118.7% (price as of 2026-10-05) |
| March 1, 2021 | CARE | P 10b5-1 | 161 | $12.27 | $1,975 | 18,135 Direct | +0.90% | Acquired | 148.7% (price as of 2026-10-05) |
| Feb. 19, 2021 | CARE | A | 2,418 | $10.92 | $26,405 | 17,974 Direct | +15.54% | Acquired | 179.4% (price as of 2026-10-05) |
| Feb. 1, 2021 | CARE | P 10b5-1 | 198 | $10.04 | $1,988 | 15,556 Direct | +1.29% | Acquired | 203.9% (price as of 2026-10-05) |
| Jan. 4, 2021 | CARE | P 10b5-1 | 186 | $10.64 | $1,979 | 15,358 Direct | +1.23% | Acquired | 186.7% (price as of 2026-10-05) |
| Dec. 1, 2020 | CARE | P 10b5-1 | 200 | $9.90 | $1,980 | 15,172 Direct | +1.34% | Acquired | 208.2% (price as of 2026-10-05) |
| March 1, 2011 | 1036070 | A | 1,510 | $14.90 | $22,499 | 30,072 Direct | +5.29% | Acquired | |
| March 1, 2011 | 1036070 | A | 3,775 | $14.90 | $56,248 | 28,562 Direct | +15.23% | Acquired | |
| Feb. 23, 2010 | 1036070 | A | 3,726 | · | · | 24,511 Direct | +17.93% | Acquired | |
| Sept. 8, 2009 | 1036070 | A | 3,250 | · | · | 20,720 Direct | +18.60% | Acquired | |
| Aug. 19, 2009 | 1036070 | S | 2,158 | $14.30 | $30,859 | 17,422 Direct | -11.02% | Disposed | |
| April 1, 2008 | 1036070 | A | 15,571 | $16.64 | $259,101 | 40,563 Direct | +62.30% | Acquired | |
| Jan. 16, 2007 | 1036070 | A | 9,005 | · | · | 9,005 Direct | · | Acquired | |
| March 3, 2006 | 1036070 | P | 1,300 | $41.13 | $53,469 | 2,739 Direct | +90.34% | Acquired | |
| March 2, 2006 | 1036070 | A | 6,532 | · | · | 6,532 Direct | · | Acquired | |
| July 15, 2005 | 1036070 | A | 1,704 | $34.75 | $59,214 | 4,126 Direct | +70.36% | Acquired | |
| July 15, 2005 | 1036070 | A | 572 | $34.75 | $19,877 | 1,439 Direct | +65.97% | Acquired | |
| April 22, 2005 | 1036070 | A | 500 | $33.73 | $16,865 | 867 Direct | +136.24% | Acquired | |
| Oct. 8, 2004 | 1036070 | A | 2,422 | $32.88 | $79,635 | 2,422 Direct | · | Acquired | |
| Oct. 8, 2004 | 1036070 | A | 367 | $32.88 | $12,067 | 367 Direct | -50.00% | Disposed |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 1, 2008 | 1036070 | Employee Stock Options | Common Stock | $19.29 | Oct. 1, 2013 | 15,571 | Acquired |
| Jan. 16, 2007 | 1036070 | Employee Stock Options | Common Stock | $31.65 | July 16, 2012 | 9,005 | Acquired |
| March 2, 2006 | 1036070 | Employee Stock Options | Common Stock | $42.13 | Sept. 1, 2011 | 6,532 | Acquired |
| July 15, 2005 | 1036070 | Employee Stock Options | Common Stock | $34.75 | Jan. 1, 2016 | 1,704 | Acquired |
| Oct. 8, 2004 | 1036070 | Employee Stock Options | Common | $32.88 | Oct. 8, 2014 | 2,422 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $703,114 | $122,648 | · | · | $183,300 | · | $46,767 | $1,355,859 |
| 2024 | $676,847 | $90,623 | · | · | $237,313 | · | $44,813 | $1,307,912 |
| 2023 | $644,618 | $96,863 | · | · | · | · | $43,149 | $784,630 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.